Navigation Links
University of Arizona research on scorpion antivenom published in NEJM
Date:5/13/2009

TUCSON, Ariz. --Youngsters suffering severe nerve poisoning following a scorpion sting recover completely and quickly if a scorpion-specific antivenom is administered, according to a study conducted by researchers from The University of Arizona and reported in the May 14 issue of The New England Journal of Medicine.

The article, "Antivenom for Critically Ill Children with Neurotoxicity from Scorpion Stings," recounts a study of 15 children conducted in Tucson, Ariz., during 2004 and 2005. All of the children had been admitted to a pediatric intensive care unit following a scorpion sting and were experiencing abnormal eye movements, uncontrolled thrashing of limbs and respiratory distress, all symptoms of nerve poisoning caused by the venom of the bark scorpion.

The principal investigator of the study and lead author of the article is Leslie Boyer, MD, director of the VIPER (Venom Immunochemistry, Pharmacology and Emergency Response) Institute at The University of Arizona College of Medicine and medical director of the Arizona Poison and Drug Information Center at the UA College of Pharmacy.

In the study, eight of the children, most of whom were under 6 years, received a scorpion antivenom that is commercially available in Mexico but is considered an investigational drug in the United States and is not approved for general use by the U.S. Food and Drug Administration. The seven other study participants received a placebo (a preparation containing no medication).

The symptoms of nerve poisoning were resolved in all of the children treated with the antivenom in less than four hours, and usually within two hours. The children who received the placebo continued to experience nerve poisoning for four hours or more and required large doses of sedative medication and extended hospitalization.

"This study told us that the dangerous effects of bark scorpion venom can be reversed quickly with the right antivenom,"
'/>"/>

Contact: Ginny Geib
geib@pharmacy.arizona.edu
520-626-3389
University of Arizona, College of Pharmacy
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Nordstrom Beat the Bridge to Beat Diabetes Run to Temporarily Suspend Traffic in University District on Sunday, May 17
2. Belmont University Graduate Launches Healthy Soul Food Restaurant on Nashvilles Historic Jefferson Street
3. University of Minnesota Physicians Chooses MedAptus Following Comprehensive Vendor Review
4. Ross University School of Medicine Expands Clinical Rotations on East Coast
5. Statement by Joseph A. Califano, Jr., Chairman and Founder, The National Center on Addiction and Substance Abuse at Columbia University and Former U.S. Secretary of Health, Education, and Welfare, on New Report by the National Association of Boards of Pha
6. University of Miami President Donna E. Shalala, Pennsylvania Gov. Edward G. Rendell: Nurse Practitioners Are Key to Obama Health Care Reform, Call for Increased Federal Funding for Innovative Nurse-Managed Health Care
7. University HealthSystem Consortium Selects Sodexo to Provide Food and Nutrition Services
8. Grand Canyon University Recognizes Nurses
9. Medical University of South Carolina Automates Grants Allocation Process with Lombardi Business Process Management Software
10. Ajou University Hospital Becomes First in Korea to Treat Using RapidArc(TM) Radiotherapy Technology from Varian Medical Systems
11. Davis Vision, Visionworks, United Concordia Dental and Louisiana State University School of Dentistry Partner with Hands on New Orleans

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009).... Centers for Disease Control and Prevention estim...d States are infected with HIV/AIDS. New research ...ny of those infected are minorities and do not hav...national strategy to facilitate education and prev...ons. , The research, which analyzed 90,000 HIV p...
(Date:11/30/2009)... Author of "My Two-Year Old E... children who love to eat everything. , ... have a picky eater in your house? Do you find yo...Three new short online videos – one focusing... the third on answers for real-life parents’...
(Date:11/30/2009)... , ENGLEWOOD, Colo., Nov. 30 ...entation discussing what "culture of safety" means...osium presentation, "Creating a Culture of Safety...professionals discussing their experiences with cu...of safety in pharmacy and the role of technology i...
(Date:11/30/2009)..., KALAMAZOO, Mich., Nov. 30 /PRNewswire-FirstCall...unced a definitive agreement to acquire privately... leader in the reprocessing and remanufacturing of...s of the agreement, Stryker will acquire Ascent He... transaction. The closing is conditioned on the ex...
(Date:11/30/2009)... N.C. Finding and treating a tumor without distur...the most effective therapies can be invasive and h...enter have devised a way they might deliver the ri...ules, called aptamers, which specifically bind to ...l of aptamers in a rodent with liver cancer until ...
Breaking Medicine News(10 mins):Health News:Research highlights need for national HIV strategy 2Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 2Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 3Health News:First live targeting of tumors with RNA-based technology 2Health News:First live targeting of tumors with RNA-based technology 3
...ss Scripts, Inc. (Nasdaq: ESRX ) announced that ...ealth Care Conference on May 19, 2009 at 10:10 a.m... , This presentation will also be broadcast via th...ws Media Player is needed to listen to the Webcast...
... 13 /PRNewswire-Asia/ -- Winner Medical Group Inc....the "Company"), today,reported unaudited financial...9. The Company,s results are detailed in its form ...eased by 15.31% over the second quarter of, ...
...vity of Cystathionase is reduced in rodent models ...and impaired generation of hydrogen sulphide, two ... and increased intrahepatic resistance. , In the p...ligand to carbon tetrachloride treated mice protec...
...ing a hallmark of hereditary hemochromatosis , is ... or non-alcoholic steatohepatitis and non-alcoholi...has investigated the link between ferritin and ste...present a risk factor for steatosis and clinical r...
...n pump inhibitor which powerfully suppresses gastr...ronic use in gastroesophageal reflux disease. Lans... unresponsive to conventional medication as a symp...e is impossible. Discontinuation of lansoprazole r...
...ial Day Is Declared "Don,t Fry Day" to Encourage S... As millions of Americans prepare to enjoy the gr...uncil on Skin Cancer Prevention reminds everyone t... rise significantly, at a rate faster than any of ...
Other Medicine News:Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 2Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 3Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 4Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 5Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 6Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 7Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 8Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 9Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 10Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 11Health News:Farnesoid X receptor regulates cystathionase 2Health News:Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole? 2Health News:The National Council on Skin Cancer Prevention Encourages Everyone to Protect Your Skin Today and Every Day 2Health News:The National Council on Skin Cancer Prevention Encourages Everyone to Protect Your Skin Today and Every Day 3
(Date:11/30/2009)...ewswire/ -- StemCyte, Inc. concluded an exclusive ...mia Sinica, the National Laboratory of Taiwan, for...erty (IP) related to the treatment of Chronic Stro...red by a team led by Professor John Lin, MD, PhD a...urrently the exclusive collaborator with StemCyte ...
(Date:11/30/2009)...30 eHealthSource.com launched the ...o products approved for Flexible Spending Account ...ite is also the first to exclusively carry value-b...s up to 75 percent on everyday healthcare needs. ...are headaches - high costs and complexity," says e...
(Date:11/30/2009)...30 Health Robotics today announced...s and product specifications,for a new and revolut...ition", a new key component of its i.v. Room of th... (Booth # 114). , "I look forward to see ...s blueprints and to find out if TPNstation appears...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3Landmark project to map genomics of complex ant systems 9188 1Landmark project to map genomics of complex ant systems 9188 2European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 1European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 2Pioneer of Digital Place Based Media Joins World 26apos 3Bs Leading Blood Pressure and Health Kiosk Manufacturer 51199 1Pioneer of Digital Place Based Media Joins World 26apos 3Bs Leading Blood Pressure and Health Kiosk Manufacturer 51199 2
...N.C., Oct. 17 Anpath Group, Inc.,(OTC Bulletin Bo...ubsidiary, EnviroSystems, Inc. (ESI) announced tha...ty (Metro) has purchased additional,supplies of it...nd a stock,of ESS high efficiency electrostatic mo...ro plans to intensify its "Cleaning for,Health" in...
...IANAPOLIS, Oct. 16 In response,to recent media sp...w drug,application (NDA), Daiichi Sankyo Company, ...E: LLY ) reiterated today that they continue to h...of this application. The,companies have not been n...application (NDA) or of any decision to have an ad...
Other Medicine Technology:Anpath Group, Inc. Advances Relationship With the Washington Metropolitan Area Transit Authority (Metro) 2Anpath Group, Inc. Advances Relationship With the Washington Metropolitan Area Transit Authority (Metro) 3Anpath Group, Inc. Advances Relationship With the Washington Metropolitan Area Transit Authority (Metro) 4Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application 2Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application 3
...ed to be your best option for cannulation using a ...of curve shapes during the procedure with a single...andle mechanism in the desired shape to address ea... Stable, Versatile Workstation. Inject contrast th...
Attain LV Leads
Hancock® II Aortic Bioprostheses
Medtronic Aortic Punches
Medicine Products: